Patents Assigned to Proteus
  • Publication number: 20050160827
    Abstract: Implantable pressure sensors and methods for making and using the same are provided. A feature of embodiments of the subject pressure sensors is that they are low-drift sensors. The subject sensors find use in a variety of applications.
    Type: Application
    Filed: December 28, 2004
    Publication date: July 28, 2005
    Applicant: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Benedict Costello
  • Publication number: 20050160825
    Abstract: Implantable pressure sensors and methods for making and using the same are provided. A feature of embodiments of the subject pressure sensors is that they are low-drift sensors. The subject sensors find use in a variety of applications.
    Type: Application
    Filed: December 28, 2004
    Publication date: July 28, 2005
    Applicant: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Benedict Costello
  • Publication number: 20050160826
    Abstract: Implantable pressure sensors and methods for making and using the same are provided. A feature of embodiments of the subject pressure sensors is that they are low-drift sensors. The subject sensors find use in a variety of applications.
    Type: Application
    Filed: December 28, 2004
    Publication date: July 28, 2005
    Applicant: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Benedict Costello
  • Publication number: 20050160823
    Abstract: Implantable pressure sensors and methods for making and using the same are provided. A feature of embodiments of the subject pressure sensors is that they are low-drift sensors. The subject sensors find use in a variety of applications.
    Type: Application
    Filed: December 28, 2004
    Publication date: July 28, 2005
    Applicant: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Benedict Costello
  • Patent number: 6911307
    Abstract: The present invention relates to a method of detection in vitro of a target substance in a sample. The sample can comprise, among other things, a nucleic sequence or more generally any type of substance. In particular, the present invention provides a method of detection comprising (i) specificly labeling a substance with a reporter gene and any sequences necessary for the in vitro expression of the reporter gene; (ii) in vitro transcription and translation of the reporter gene; and (iii) in vitro detection of a reporter protein coded by the reporter gene.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 28, 2005
    Assignee: Proteus S.A.
    Inventors: Sandrine Dautel, Cécile Persillon, Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Patent number: 6855364
    Abstract: A meat or fish composition which retains moisture during cooking is provided. A dry protein mixture or an aqueous acidic protein solution derived from animal muscle tissue is added to the meat or fish prior to cooking. The dry protein mixture and aqueous acidic protein solution comprise myofibrillar proteins and sarcoplasmic proteins substantially free of myofibrils and sarcomeres.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: February 15, 2005
    Assignee: Proteus Industries, INC
    Inventors: Stephen D. Kelleher, Peter G. Williamson
  • Patent number: 6818396
    Abstract: The invention concerns a method for determining the activity of a substance using a functional test, characterized in that it consists in detecting and/or measuring the variation of a known function corresponding to one or several proteins produced in vitro in the presence and in the absence of said substances or to the substance in the presence or in the absence of one or several proteins produces in vitro.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 16, 2004
    Assignee: Proteus S.A.
    Inventors: Jean François Bloch, Daniel Dupret, Fabrice Lefevre, Sandrine Dautel, Jean-Michel Masson
  • Publication number: 20040215049
    Abstract: A cardiac sensor system includes implanted cardiac sensor assemblies and an external controller which receives information from the implanted sensors. The sensors permit direct measurement of a number of physiologic parameters. The external controller permits calculation of a variety of performance values based on the measured physiological parameters. Optionally, patient oxygen consumption can be measured externally and combined with the internally measured physiologic parameters in order to calculate a variety of unique performance values.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Applicant: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Joseph M. Ruggio
  • Publication number: 20040193021
    Abstract: A multiplexed medical carrier provides for sensing one or more patient parameters and/or delivering energy via separately identifiable effectors. The carrier includes a body and at least two electrical conductors coupled with at least two effectors. Effectors may be any combination of sensors, actuators or both. Sensors may measure such parameters as pressure, oxygen content, volume, conductivity, fluid flow rate, or any other chemical or physical parameters. Actuators may be used, for example, to pace a heart, stimulate muscle or neural tissue, broadcast ultrasonic energy, emit light, heat or other forms of radiation, or deliver any form of energy or substance. A method for collecting medical data from a patient includes interrogating a network of multiplexed sensors residing on parallel conductors in the patient, including addressing a first addressable sensor in the network to obtain data and addressing a second addressable sensor in the network to obtain data.
    Type: Application
    Filed: December 11, 2003
    Publication date: September 30, 2004
    Applicant: Proteus Biomedical, Inc., a Delaware Corporation
    Inventors: Mark Zdeblick, George M. Savage
  • Patent number: 6730123
    Abstract: The present invention provides an intra-ocular lens (IOL) whose focusing performance can be modified after its implantation in the eye without a need for any invasive procedure. An IOL of the invention has an optical chamber having at least a flexible region that is deformable under influence of a fluid. The IOL further include a reservoir for storing an optical fluid in fluid communication with the optical chamber, and a valve that regulates the fluid communication between the reservoir and the optical chamber. The lens can also include a pump that is actuated by an external energy source to transfer the optical fluid between the reservoir and the optical chamber to change the amount of fluid in the optical chamber, thereby modifying the focusing performance of the IOL.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: May 4, 2004
    Assignee: Proteus Vision, LLC
    Inventor: Peter J. Klopotek
  • Publication number: 20040002101
    Abstract: Method and kit for using in vitro expression to discover nucleic acids that encode desired functions. Either the existence, presence, identity, properties or function of one or more of the nucleic acids from the sample is unknown to at least the experimenter performing the method or using the kit.
    Type: Application
    Filed: April 11, 2003
    Publication date: January 1, 2004
    Applicant: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Publication number: 20030199013
    Abstract: Synthetic polypeptides having at least one antigenic site of a prior protein, methods for their use and manufacture, antibodies raised against such polypeptides and diagnostic kits containing these polypeptides or antibodies.
    Type: Application
    Filed: April 5, 2002
    Publication date: October 23, 2003
    Applicant: Proteus Molecular Design Limited
    Inventors: Robert Vincent Fishleigh, Barry Robson, Roger Paul Mee
  • Publication number: 20030199017
    Abstract: This invention has as its object a method for releasing a product by subjecting a compound of Formula (II′): R′7R′8(HX)C1-C2(YH)R′9R′10 to a chemical oxidation that cleaves the bond C1-C2 to obtain the product. In the compound of Formula (II′): R′7 to R′10, which are identical or different, correspond to a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted functional group; X and Y, which are identical or different, are an oxygen atom, a sulfur atom, or an amine of Formula -NR11R12, wherein R11 is a hydrogen atom, an alkyl group, or a substituted or unsubstituted aryl group, and R12 is not a hydrogen atom. The invention also has as its object a method for releasing a product that comprises, before the chemical oxidation stage, a first step for preparing the compound of Formula (II′). The released product can be a volatile molecule or an active substance or else a specific product.
    Type: Application
    Filed: December 2, 2002
    Publication date: October 23, 2003
    Applicant: Proteus
    Inventors: Jean-Louis Reymond, Denis Wahler, Frabrizzio Badalassi, Hong-Khanh Nguyen
  • Publication number: 20030104417
    Abstract: Method of gene shuffling using oriented ligation, whereby at least two fragments are adjacently hybridized on an assembly template. Invention is particularly aimed at generating novel polynucleotides that differ in some advantageous respect compared to a reference sequence. Invention further includes sequences created by the method, hosts and vectors containing same, and proteins translated therefrom.
    Type: Application
    Filed: April 25, 2002
    Publication date: June 5, 2003
    Applicant: Proteus S.A.
    Inventors: Daniel Dupret, Jean Michel Masson, Fabrice Lefevre
  • Patent number: 6514703
    Abstract: The present invention is directed to a process for the separation and characterization of the functions potentially present in a biological sample containing nucleic acids, characterized in that it comprises the steps of preparation of nucleic acid fragments starting from said sample, association of each one of said fragments with a vector molecule, isolation of each fragment associated with a vector molecule or with a part of each construction composed of a fragment associated with a vector molecule, in vitro treatment of each fragment associated with a vector molecule or of a part of each construction composed of a fragment associated with a vector molecule to obtain transcripts, and testing of the function of the transcripts or of the proteins encoded thereby after translation of said transcripts.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 4, 2003
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Publication number: 20020197467
    Abstract: A process for modifying the surface of a polymeric substrate is disclosed, wherein said process is comprised of contacting a surface of a polymeric substrate with a protic liquid or fluid containing a diazonium composition under such conditions that will effectively allow the reaction of the diazonium composition with the surface, resulting in the attachment of aromatic groups to the polymeric surface. The polymeric substrate contains aliphatic carbon-hydrogen bonds, while the protic composition is comprised of a diazonium complex formed by diazotizing an amino compound comprised of at least one amino group bonded to an aromatic group. Also disclosed are the products generated using the aforementioned surface modifications.
    Type: Application
    Filed: February 20, 2002
    Publication date: December 26, 2002
    Applicant: Proteus Corporation
    Inventor: Joseph Edward Johnson
  • Patent number: 6379905
    Abstract: Synthetic polypeptides having at least one antigenic site of a prion protein, methods for their use and manufacture, antibodies raised against such polypeptides and diagnostic kits containing these polypeptides or antibodies.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: April 30, 2002
    Assignee: Proteus Molecular Design Limited
    Inventors: Robert Vincent Fishleigh, Barry Robson, Roger Paul Mee
  • Patent number: 6364875
    Abstract: A method and apparatus to alter the shape of the cornea of an eye provides for heating a portion of the cornea to a temperature not exceeding the collagen shrinkage temperature, and applying a pressure differential to a portion of the cornea. The combined effect of elevated temperature and stretching forces leads to permanent residual strains in preferred directions, and thus to a permanent new shape of the cornea. The method is applicable to the correction or reduction of myopia, hyperopia, and astigmatism.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: April 2, 2002
    Assignee: Proteus Therapeutics, Inc.
    Inventor: H. Mark Stanley, III
  • Publication number: 20010024119
    Abstract: The in-situ robotic testing system uses a robotic probe positioning apparatus, attached to the system under test, to position the probe head and its associated probe tip at a selected location on the printed circuit board under test. Access to the printed circuit board under test is facilitated by the removal of the printed circuit board in the adjacent slot in the card cage. The robotic probe positioning apparatus comprise motors and associated control software. The control software can process user input and direct the motors to place the probe tip. The control software also directs the probe to perform the testing and provides the test results to the user. X-axis, Y-axis and Z-axis motors are used to control the linear movement of the probe head and two rotational motors control the position and orientation of the probe tip relative to the circuitry and engage the probe tip with the particular circuit trace on the printed circuit board.
    Type: Application
    Filed: January 12, 2001
    Publication date: September 27, 2001
    Applicant: Proteus Corporation
    Inventor: Brian Stockford
  • Patent number: D489138
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: April 27, 2004
    Assignee: Proteus Technical Solutions, Inc.
    Inventors: Kenneth E. Tyson, Deborah S. Tyson, Theodore Marzan, Ronald B. Walker